Stem Cells

Researcher reports on new embryonic stem cell medium

Published in Blood Weekly, November 13th, 2003

ThromboGenics Ltd. announced that Dr. Jean Marie Stassen, head of research and development and a leading European researcher in pre-clinical cardiovascular therapeutics, presented "An Improved Medium for Stem Cell Culture" at the Stem Cells Regenerative Medicine conference in Princeton, New Jersey, on October 15, 2003.

Dr. Stassen spoke about a new embryonic stem (ES) cell culture medium developed by Thromb-X, NV, the research and development subsidiary of ThromboGenics, in Leuven, Belgium. The proprietary ES cell culture medium (called TX-WES), conditioned by a fibroblast cell line, allows derivation and maintenance of ES cell lines from all inbred mouse strains...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-11-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry